After 20 years as a neuroscience research tool, DREADDs are entering the clinic, with new trials exploring chemogenetic therapies for epilepsy, Parkinson’s disease and more 🧠

Here, we take a closer look at what might come next for DREADDs: ow.ly/RiiA50ZOIQ6

#Neuroscience #DREADDs #Parkinsons